@article{boussemart:hal-02020674, TITLE = {{Tumor mutational burden and response to PD-1 inhibitors in a case series of patients with metastatic desmoplastic melanoma}}, AUTHOR = {Boussemart, Lise and Johnson, Adrienne and Schrock, Alexa B and Pal, Sumanta K and Frampton, Garrett M and Fabrizio, David and Chalmers, Zachary and Lotem, Michal and Gibney, Geoffrey and Russell, Jeffery and Chmielowski, Bartosz and Ross, Jeffrey S and Stephens, Philip J and Miller, Vincent A and Ali, Siraj M}, URL = {https://univ-rennes.hal.science/hal-02020674}, JOURNAL = {{Journal of The American Academy of Dermatology}}, PUBLISHER = {{Elsevier}}, VOLUME = {80}, NUMBER = {6}, PAGES = {1780-1782}, YEAR = {2019}, MONTH = Jun, DOI = {10.1016/j.jaad.2018.12.020}, KEYWORDS = {pembrolizumab ; hypermutated ; PD-1 ; UV signature ; Desmoplastic melanoma}, PDF = {https://univ-rennes.hal.science/hal-02020674/file/Tumor%20mutational%20burden%20and%20response%20to%20PD-1%20inhibitors.pdf}, HAL_ID = {hal-02020674}, HAL_VERSION = {v1}, }